This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cost‐effectiveness analysis of trastuzumab emtansine (T‐DM1) in treating HER‐2 positive advanced breast cancer in Taiwan. Issue 10 (17th September 2020)
Record Type:
Journal Article
Title:
Cost‐effectiveness analysis of trastuzumab emtansine (T‐DM1) in treating HER‐2 positive advanced breast cancer in Taiwan. Issue 10 (17th September 2020)
Main Title:
Cost‐effectiveness analysis of trastuzumab emtansine (T‐DM1) in treating HER‐2 positive advanced breast cancer in Taiwan